Identification of the Staphylococcus aureus vfrAB operon, a novel virulence factor regulatory locus

Infection and Immunity

Volumn 82, Issue 5, 2014, Pages 1813-1822

  Bose, Jeffrey L ^a   Daly, Seth M ^b   Hall, Pamela R ^b   Bayles, Kenneth W ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CONTROLLED STUDY; GENE CONTROL; GENE DISRUPTION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENETIC TRANSCRIPTION; HEMOLYSIS; HLA SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OPEN READING FRAME; OPERON; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; RNA TRANSLATION; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENOME, BACTERIAL; MICE; MUTATION; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE; VIRULENCE FACTORS;

EID: 84898901242     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01655-13     Document Type: Article

References (55)

1. Kobayashi SD, DeLeo FR. 2009. An update on community-associated MRSA virulence. Curr. Opin. Pharmacol. 9:545-551. http://dx.doi.org/10.1016/j.coph.2009.07.009.
2. Nizet V. 2007. Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J. Allergy Clin. Immunol. 120:13-22. http://dx.doi.org/10.1016/j.jaci.2007.06.005.
3. Bhakdi S, Muhly M, Korom S, Hugo F. 1989. Release of interleukin-1β associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect. Immun. 57:3512-3519.
4. McGee MP, Kreger A, Leake ES, Harshman S. 1983. Toxicity of staphylococcal alpha toxin for rabbit alveolar macrophages. Infect. Immun. 39:439-444.
5. Bramley AJ, Patel AH, O'Reilly M, Foster R, Foster TJ. 1989. Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect. Immun. 57:2489-2494.
6. Bubeck Wardenburg J, Bae T, Otto M, DeLeo FR, Schneewind O. 2007. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13:1405-1406. http://dx.doi.org/10.1038/nm1207-1405.
7. Bubeck Wardenburg J, Patel RJ, Schneewind O. 2007. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect. Immun. 75:1040-1044. http://dx.doi.org/10.1128/IAI.01313-06.
8. Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, Long D, Bubeck Wardenburg J, Schneewind O, Otto M, DeLeo FR. 2011. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J. Infect. Dis. 204:937-941. http: //dx.doi.org/10.1093/infdis/jir441.
9. Patel AH, Nowlan P, Weavers ED, Foster T. 1987. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect. Immun. 55:3103-3110.
10. Rauch S, DeDent AC, Kim HK, Bubeck Wardenburg J, Missiakas DM, Schneewind O. 2012. Abscess formation and alpha-hemolysin induced toxicity in a mouse model of Staphylococcus aureus peritoneal infection. Infect. Immun. 80:3721-3732. http://dx.doi.org/10.1128/IAI.00442-12.
11. van der Vijver JC, van Es-Boon MM, Michel MF. 1975. A study of virulence factors with induced mutants of Staphylococcus aureus. J. Med. Microbiol. 8:279-287. http://dx.doi.org/10.1099/00222615-8-2-279.
12. Berube BJ, Bubeck Wardenburg J. 2013. Staphylococcus aureus alphatoxin: nearly a century of intrigue. Toxins (Basel) 5:1140-1166. http://dx.doi.org/10.3390/toxins5061140.
13. Giraudo AT, Cheung AL, Nagel R. 1997. The sae locus of Staphylococcus aureus controls exoprotein synthesis at the transcriptional level. Arch. Microbiol. 168:53-58. http://dx.doi.org/10.1007/s002030050469.
14. Blevins JS, Beenken KE, Elasri MO, Hurlburt BK, Smeltzer MS. 2002. Strain-dependent differences in the regulatory roles of sarA and agr in Staphylococcus aureus. Infect. Immun. 70:470-480. http://dx.doi.org/10.1128/IAI.70.2.470-480.2002.
15. Zielinska AK, Beenken KE, Joo HS, Mrak LN, Griffin LM, Luong TT, Lee CY, Otto M, Shaw LN, Smeltzer MS. 2011. Defining the straindependent impact of the staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of Staphylococcus aureus. J. Bacteriol. 193:2948-2958. http://dx.doi.org/10.1128/JB.01517-10.
16. Schmidt KA, Manna AC, Gill S, Cheung AL. 2001. SarT, a repressor of alpha-hemolysin in Staphylococcus aureus. Infect. Immun. 69:4749-4758. http://dx.doi.org/10.1128/IAI.69.8.4749-4758.2001.
17. McNamara PJ, Milligan-Monroe KC, Khalili S, Proctor RA. 2000. Identification, cloning, and initial characterization of rot, a locus encoding a regulator of virulence factor expression in Staphylococcus aureus. J. Bacteriol. 182:3197-3203. http://dx.doi.org/10.1128/JB.182.11.3197-320 3.2000.
18. Fournier B, Klier A, Rapoport G. 2001. The two-component system ArlS-ArlR is a regulator of virulence gene expression in Staphylococcus aureus. Mol. Microiol. 41:247-261. http://dx.doi.org/10.1046/j.1365-2958.2001.02515.x.
19. Burnside K, Lembo A, de Los Reyes M, Iliuk A, Binhtran NT, Connelly JE, Lin WJ, Schmidt BZ, Richardson AR, Fang FC, Tao WA, Rajagopal L. 2010. Regulation of hemolysin expression and virulence of Staphylococcus aureus by a serine/threonine kinase and phosphatase. PLoS One 5:e11071. http://dx.doi.org/10.1371/journal.pone.0011071.
20. Morfeldt E, Taylor D, von Gabain A, Arvidson S. 1995. Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J. 14:4569-4577.
21. Kolar SL, Ibarra JA, Rivera FE, Mootz JM, Davenport JE, Stevens SM, Horswill AR, Shaw LN. 2013. Extracellular proteases are key mediators of Staphylococcus aureus virulence via the global modulation of virulencedeterminant stability. Microbiologyopen 2:18-34. http://dx.doi.org/10.1002/mbo3.55.
22. Zielinska AK, Beenken KE, Mrak LN, Spencer HJ, Post GR, Skinner RA, Tackett AJ, Horswill AR, Smeltzer MS. 2012. sarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates. Mol. Microbiol. 86:1183-1196. http://dx.doi.org/10.1111/mmi.12048.
23. Goerke C, Fluckiger U, Steinhuber A, Zimmerli W, Wolz C. 2001. Impact of the regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of alpha-toxin during device-related infection resolved by direct quantitative transcript analysis. Mol. Microbiol. 40:1439-1447. http://dx.doi.org/10.1046/j.1365-2958.2001.02494.x.
24. Gonzalez DJ, Okumura CY, Hollands A, Kersten R, Akong-Moore K, Pence MA, Malone CL, Derieux J, Moore BS, Horswill AR, Dixon JE, Dorrestein PC, Nizet V. 2012. Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. J. Biol. Chem. 287:13889-13898. http://dx.doi.org/10.1074/jbc.M112.349860.
25. Karlsson A, Saravia-Otten P, Tegmark K, Morfeldt E, Arvidson S. 2001. Decreased amounts of cell wall-associated protein A and fibronectinbinding proteins in Staphylococcus aureus sarA mutants due to upregulation of extracellular proteases. Infect. Immun. 69:4742-4748. http: //dx.doi.org/10.1128/IAI.69.8.4742-4748.2001.
26. McAleese FM, Walsh EJ, Sieprawska M, Potempa J, Foster TJ. 2001. Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease. J. Biol. Chem. 276:29969-29978. http://dx.doi.org/10.1074 /jbc.M102389200.
27. McGavin MJ, Zahradka C, Rice K, Scott JE. 1997. Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease. Infect. Immun. 65:2621-2628.
28. Imamura T, Tanase S, Szmyd G, Kozik A, Travis J, Potempa J. 2005. Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus. J. Exp. Med. 201:1669-1676. http://dx.doi.org/10.1084/jem.20042041.
29. Laarman AJ, Mijnheer G, Mootz JM, van Rooijen WJ, Ruyken M, Malone CL, Heezius EC, Ward R, Milligan G, van Strijp JA, de Haas CJ, Horswill AR, van Kessel KP, Rooijakkers SH. 2012. Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis. EMBO J. 31:3607-3619. http://dx.doi.org/10.1038 /emboj.2012.212.
30. Massimi I, Park E, Rice K, Muller-Esterl W, Sauder D, McGavin MJ. 2002. Identification of a novel maturation mechanism and restricted substrate specificity for the SspB cysteine protease of Staphylococcus aureus. J. Biol. Chem. 277:41770-41777. http://dx.doi.org/10.1074/jbc.M20716 2200.
31. Potempa J, Dubin A, Korzus G, Travis J. 1988. Degradation of elastin by a cysteine proteinase from Staphylococcus aureus. J. Biol. Chem. 263:2664-2667.
32. Potempa J, Watorek W, Travis J. 1986. The inactivation of human plasma α1-proteinase inhibitor by proteinases from Staphylococcus aureus. J. Biol. Chem. 261:14330-14334.
33. Prokesova L, Potuznikova B, Potempa J, Zikan J, Radl J, Hachova L, Baran K, Porwit-Bobr Z, John C. 1992. Cleavage of human immunoglobulins by serine proteinase from Staphylococcus aureus. Immunol. Lett. 31:259-265. http://dx.doi.org/10.1016/0165-2478(92)90124-7.
34. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J. 2004. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48:4673-4679. http://dx.doi.org/10.1128/AAC.48.12.4673-4679.2004.
35. Fey PD, Endres JL, Yajjala VK, Widhelm TJ, Boissy RJ, Bose JL, Bayles KW. 2013. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. mBio 4:e00537-12. http://dx.doi.org/10.1128/mBio.00537-12.
36. Bose JL, Fey PD, Bayles KW. 2013. Genetic tools to enhance the study of gene function and regulation in Staphylococcus aureus. Appl. Environ. Microbiol. 79:2218-2224. http://dx.doi.org/10.1128/AEM.00136-13.
37. Kreiswirth BN, Lofdahl S, Betley MJ, O'Reilly M, Schlievert PM, Bergdoll MS, Novick RP. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305:709-712. http://dx.doi.org/10.1038/305709a0.
38. Bose JL, Lehman MK, Fey PD, Bayles KW. 2012. Contribution of the Staphylococcus aureus Atl AM and GL murein hydrolase activities in cell division, autolysis, and biofilm formation. PLoS One 7:e42244. http://dx.doi.org/10.1371/journal.pone.0042244.
39. Boles BR, Thoendel M, Roth AJ, Horswill AR. 2010. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 5:e10146. http://dx.doi.org/10.1371/journal.pone.0010146.
40. Bernheimer AW. 1988. Assay of hemolytic toxins. Methods Enzymol. 165:213-217. http://dx.doi.org/10.1016/S0076-6879(88)65033-6.
41. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
42. Malachowa N, Kobayashi SD, Braughton KR, DeLeo FR. 2013. Mouse model of Staphylococcus aureus skin infection. Methods Mol. Biol. 1031: 109-116. http://dx.doi.org/10.1007/978-1-62703-481-4_14.
43. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9:671-675. http://dx.doi.org/10.1038/nmeth.2089.
44. Malone CL, Boles BR, Lauderdale KJ, Thoendel M, Kavanaugh JS, Horswill AR. 2009. Fluorescent reporters for Staphylococcus aureus. J. Microbiol. Methods 77:251-260. http://dx.doi.org/10.1016/j.mimet.2009.02.011.
45. Cheung AL, Bayer AS, Zhang G, Gresham H, Xiong YQ. 2004. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 40:1-9. http://dx.doi.org/10.1016/S0928-8244(03)00309-2.
46. Ohlsen K, Koller KP, Hacker J. 1997. Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla::lacZ gene fusion. Infect. Immun. 65:3606-3614.
47. Rice K, Peralta R, Bast D, de Azavedo J, McGavin MJ. 2001. Description of Staphylococcus serine protease (ssp) operon in Staphylococcus aureus and nonpolar inactivation of sspA-encoded serine protease. Infect. Immun. 69:159-169. http://dx.doi.org/10.1128/IAI.69.1.159-169.2001.
48. Drapeau GR. 1978. Role of metalloprotease in activation of the precursor of staphylococcal protease. J. Bacteriol. 136:607-613.
49. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674. http://dx.doi.org/10.1056/NEJMoa055356.
50. Lowy FD. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532. http://dx.doi.org/10.1056/NEJM199808203390806.
51. Tong SY, Chen LF, Fowler VG, Jr. 2012. Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance? Semin. Immunopathol. 34:185-200. http://dx.doi.org /10.1007/s00281-011-0300-x.
52. Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-Salim B, Porcella SF, Long RD, Dorward DW, Gardner DJ, Kreiswirth BN, Musser JM, DeLeo FR. 2005. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 175:3907-3919.
53. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D, Long RD, Dorward DW, Gardner DJ, Lina G, Kreiswirth BN, DeLeo FR. 2006. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J. Infect. Dis. 194:1761-1770. http://dx.doi.org/10.1086/509506.
54. Erni B, Siebold C, Christen S, Srinivas A, Oberholzer A, Baumann U. 2006. Small substrate, big surprise: fold, function and phylogeny of dihydroxyacetone kinases. Cell. Mol. Life Sci. 63:890-900. http://dx.doi.org /10.1007/s00018-005-5518-0.
55. Wormann ME, Reichmann NT, Malone CL, Horswill AR, Grundling A. 2011. Proteolytic cleavage inactivates the Staphylococcus aureus lipoteichoic acid synthase. J. Bacteriol. 193:5279-5291. http://dx.doi.org/10.1128/JB.00369-11.